In Q1 FY2026 (ended March 31, 2026), Bruker Corp reported revenue of $823.4 million, up 2.7% year-over-year. Net income fell 17.2% to $14.4 million, while diluted EPS dropped 81.8% to $0.02. Operating income declined sharply by 67.9% to $10.2 million. The company had $133.4 million in cash and $1.67 billion in long-term debt as of quarter end.
•Revenue grew 2.7% YoY to $823.4M.
•Net income decreased 17.2% to $14.4M.
•Diluted EPS fell 81.8% to $0.02.
•Operating income dropped 67.9% to $10.2M.
Informational summary based on SEC XBRL figures · generated by deepseek-v4-flash. Not investment advice.
Bruker develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. Its business is organized into four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation.
Its portfolio also includes life science tools, innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products, solutions for in-vivo processes and drug discovery, aftermarket solutions, solutions for lab automation and digitalization, mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies, genotype and fluorotype molecular diagnostics kits, and research, analytical, and process analysis instruments and solutions, as well as range of portable analytical and bioanalytical detection systems, and related products.
Its portfolio also includes X-ray instruments, analytical tools for electron microscopes Handheld, portable, and mobile X-ray fluorescence spectrometry instruments, atomic force microscopy instrumentation, non-contact nanometer resolution solution topography, and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. Additionally, it offers advanced optical fluorescence microscopy instruments.
Its portfolio also includes services for transcriptional profiling and multiomic analysis, superconducting materials, such as metallic low temperature superconductors, multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats, designs and manufactures Cuponal, metallic low temperature superconductors, and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Founded in 1960, Bruker is headquartered in Billerica, Massachusetts.
Bruker Corporation develops, manufactures, and distributes scientific instruments and analytical and diagnostic solutions. Its business is organized into four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscopy, preclinical imaging, biopharma and applied solutions, services and lifecycle support, integrated data solutions, and automation. Its portfolio includes life science tools, nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products, solutions for in-vivo processes and drug discovery, aftermarket solutions, lab automation and digitalization, mass spectrometry solutions and test kits, DNA test strips, fluorescence-based PCR technologies, genotype and fluorotype molecular diagnostics kits, and research, analytical, and process analysis instruments. It also provides X-ray instruments, analytical tools for electron microscopes, handheld and portable X-ray fluorescence spectrometry instruments, atomic force microscopy instrumentation, non-contact nanometer resolution topography, automated X-ray metrology, automated AFM defect-detection, photomask repair and cleaning equipment, advanced optical fluorescence microscopy instruments, and services for transcriptional profiling and multiomic analysis.
Where is Bruker Corporation (BRKR) listed and in which currency?
Bruker Corporation is listed on the Nasdaq Global Select Market (NasdaqGS) under the ticker symbol BRKR. Its stock trades in United States Dollars (USD), as the company is based in the United States. The exchange is one of the major stock exchanges in the world, providing liquidity and visibility for the company's shares.
What sector and industry does Bruker Corporation (BRKR) belong to?
Bruker Corporation operates in the Healthcare sector, specifically within the Medical Devices industry. This classification reflects the company's focus on developing scientific instruments and analytical solutions used in medical diagnostics, life sciences research, and clinical applications. The Medical Devices industry includes companies that produce equipment, instruments, and supplies for healthcare and research purposes.
Where is Bruker Corporation (BRKR) headquartered and what markets does it serve?
Bruker Corporation is headquartered in the United States, as indicated by its country and region being 'United States' and 'us'. While the provided data does not specify a city, the company serves global markets through its four business segments. Its products are used in academic research, pharmaceutical development, clinical diagnostics, industrial analysis, and materials science. The company's offerings, such as NMR and mass spectrometry instruments, are utilized by customers worldwide, including research institutions, hospitals, and industrial laboratories.